| Name | Title | Contact Details |
|---|
Lubbock Artificial Limb Co Inc is a Lubbock, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Caliva, San Jose`s premier medical marijuana dispensary and cultivation facility opened in July of 2015 and in September of 2016 was ranked #1 dispensary in the nation by Business Insider. Our facility is one of the most advanced pharmaceutical-grade cannabis cultivating, manufacturing, and dispensing facilities in the country and a model for energy efficiency, safe access, and compliance. We started Caliva because we believe strongly in the medicinal and wellness applications of cannabis. From inception, our goal has been to establish a regulated, safe and consistent source of cannabis for our patients. We believe strongly in a medical cannabis industry that is well-regulated, highly professional, and rigorously secure. Each one of our strains is selected for its genetics and superior medicinal effects and then tested to ensure that the quality we offer is only the best. Our attitude is easy, but our focus is to provide the highest level of service in the industry; our educated and passionate team provide a comfortable, safe and easy buying experience.
General Project Business Development Office is a Phillipsburg, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Motus GI Holdings, Inc. (NASDAQ: MOTS) is a medical technology company based in the U.S., with subsidiaries in the U.S. and Israel, dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. The Company is focused on the development and commercialization of the Pure-Vu® System, designed to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.
RF Surgical Systems, Inc. is a medical device company with headquarters in Bellevue, Washington and engineering R & D facilities in San Diego, California. The advanced technologies used in the RF Surgical Detection System are protected by U.S. patents. Regulatory clearance to market the system was granted by the U.S. Food and Drug Administration in November of 2006